osimertinib
astrazeneca
['adaura', 'nsclc', 'sclc', 'osimertinib', 'aura ,(-laura)']
. highlights new data from the adaura trial, first presented at #asco23, on how osimertinib after surgery in adults with egfr-mutated, stage ib, ii, or iiia nsclc significantly improves survival. see the data 
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.